Renowned Breast Surgeon, David Weintritt, MD, Leads Clinical Study for New FDA-Approved Technology in Breast Cancer Surgery that Can Reduce Debilitating Lymphedema to as Low as 5%
FAIRFAX, Va., Oct. 22, 2024 /PRNewswire/ — Virginia Cancer Specialists, the largest private cancer practice in Northern Virginia, and an affiliate of The US Oncology Network, announced today one of its renowned breast surgeons, David Weintritt, MD, known for his innovative surgical approache
Waze Co-founder and former Infosys board member, Uri Levine, Returns to Zoomcar in Strategic Advisory Role
BENGALURU, India, Oct. 22, 2024 /PRNewswire/ — Zoomcar Holdings, Inc. (“Zoomcar” or the “Company”) (NASDAQ: ZCAR), the Nasdaq-listed leading marketplace for self-drive car sharing, welcomes back Waze Co-Founder Uri Levine as the Strategic and Financial Advisor. Mr. Levi
Aurachain Unveils Advanced AI Features to Transform Organizations and Drive ROI
ZURICH, Oct. 22, 2024 /PRNewswire/ — Aurachain, a leader in low-code enterprise solutions, is taking process automation to the next level with the release of its new AI capabilities. Designed to streamline operations, accelerate decision-making, and unlock significant efficiencies, these enha
Guide Outdoor Releases the Powerhouse TS Gen2 Series Built for Hunting
NUREMBERG, Germany, Oct. 22, 2024 /PRNewswire/ — With the start of hunting season, Guide outdoor introduces the new TS Gen2 Series thermal imaging scope for hunters and outdoor enthusiasts. As a specialist in outdoor optics, Guide outdoor enhances visual performance with a high-sensitive 12μm
CLEAN EATZ CELEBRATES Q3 ACHIEVEMENTS AND FRANCHISEE SUCCESS AT 2024 ANNUAL CONVENTION
Fast-growing brand expands national footprint, cements leadership in healthier eating WILMINGTON, N.C., Oct. 22, 2024 /PRNewswire/ — Clean Eatz, a health-focused lifestyle brand and meal plan franchise, wrapped Q3 with a celebration of its growth and brand achievements as well as individual f
Syra Health To Discuss Third Quarter 2024 Financial Results
Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA), (“Syra Health” or the “Company”), a healthcare technology company powering better health by providing meaningful solutions, a
Frontera Announces Completion of Substantial Issuer Bid
CALGARY, AB, Oct. 22, 2024 /PRNewswire/ – Frontera Energy Corporation (TSX: FEC) (“Frontera” or the “Company“) announces that the Company has taken up and paid for 3,375,000 of its outstanding common shares (the “Shares“) at a price of $12.00 per Share (the
iFLYTEK Smart Translator: Revolutionizing Global Communication with AI Innovation
DUBAI, UAE, Oct. 22, 2024 /PRNewswire/ — At GITEX Global 2024, iFLYTEK unveiled its cutting-edge Smart Translator for the first time in the Middle East. As a leader in artificial intelligence-powered translation solutions, iFLYTEK’s Smart Translator has been recognized globally for its i
TECNO Reveals Winners of Shot On CAMON Photography Contest 2024
Empowering the great passion for photography, TECNO’s first-ever global photography contest has encouraged consumers in emerging markets to unleash their talent and extraordinary creativity, anytime, anywhere, and tell their story to the world through the creative lens in their hands. HONG KON
Affinia Therapeutics to Highlight New Data on Genetic Cardiomyopathy Programs and BBB-Penetrant Capsids Leveraging Novel Receptors at the European Society of Gene & Cell Therapy 2024 31st Annual Congress
AFTX-201, Affinia’s gene therapy program in BAG3 dilated cardiomyopathy, demonstrates efficacy, safety, and differentiation in a genetically relevant preclinical model, with full restoration of cardiac function Additional data show Affinia’s gene therapy program in MYBPC3 hypertrophic ca
